Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: DSS008
MIFTS: 57

Disease of Mental Health

Categories: Mental diseases, Neuronal diseases
Genes Variations Tissues Related diseases Publications Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Disease of Mental Health

About this section

MalaCards integrated aliases for Disease of Mental Health:

Name: Disease of Mental Health 12 15
Mental Disorders 43 71
Mental Health 42 17

Classifications:

MalaCards categories:
Anatomical: Mental diseases Neuronal diseases
See all MalaCards categories (disease lists)
ICD10: 32


External Ids:

Disease Ontology 12 DOID:150
MeSH 43 D001523
NCIt 49 C2893
SNOMED-CT 67 74732009
UMLS 71 C0004936
Sources

Summaries for Disease of Mental Health

About this section
MedlinePlus : 42 What is mental health? Mental health includes our emotional, psychological, and social well-being. It affects how we think, feel, and act as we cope with life. It also helps determine how we handle stress, relate to others, and make choices. Mental health is important at every stage of life, from childhood and adolescence through adulthood. What are mental illnesses? Mental illnesses are serious disorders which can affect your thinking, mood, and behavior. They may be occasional or long-lasting. They can affect your ability to relate to others and function each day. Mental disorders are common; more than half of all Americans will be diagnosed with a mental disorder at some time in their life. But there are treatments. People with mental health problems can get better, and many of them recover completely. Why is mental health important? Mental health is important because it can help you to Cope with the stresses of life Be physically healthy Have good relationships Make meaningful contributions to your community Work productively Realize your full potential How can I improve my mental health? There are steps you can take to help you improve your mental health. They include Staying positive Being physically active Connecting with others Developing a sense of meaning and purpose in life Getting enough sleep Developing coping skills Meditating Getting professional help if you need it

MalaCards based summary : Disease of Mental Health, also known as mental disorders, is related to bipolar disorder and depression, and has symptoms including agitation, lethargy and forgetful. An important gene associated with Disease of Mental Health is BDNF-AS (BDNF Antisense RNA). The drugs Morphine and Coal tar have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and heart, and related phenotype is integument.

Disease Ontology : 12 A disease that involves a psychological or behavioral pattern generally associated with subjective distress or disability that occurs in an individual, and which are not a part of normal development or culture.

Wikipedia : 74 A mental disorder, also called a mental illness or psychiatric disorder, is a behavioral or mental... more...

Sources

Related Diseases for Disease of Mental Health

About this section

Diseases related to Disease of Mental Health via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1075)
# Related Disease Score Top Affiliating Genes
1 bipolar disorder 34.0 SLC6A4 PRODH MIR132 KDM4C DRD2 BDNF
2 depression 33.9 SLC6A4 BDNF-AS BDNF
3 anxiety 33.8 SLC6A4 PRODH DRD2 BDNF APP APOE
4 major depressive disorder 33.7 SLC6A4 MIR132 DRD2 BDNF APOE
5 post-traumatic stress disorder 33.7 SLC6A4 DRD2 BDNF APOE
6 schizophrenia 33.7 SLC6A4 SERPINA3 PRODH MIR9-1 MIR132 DRD2
7 dementia 33.7 SERPINA3 DRD2 BDNF APP APOE
8 obsessive-compulsive disorder 33.7 SLC6A4 DRD2 BDNF APOE
9 pervasive developmental disorder 33.5 SLC6A4 PRODH MIR9-1 MIR24-1 MIR132 KDM4C
10 schizoaffective disorder 33.5 SLC6A4 PRODH DRD2 BDNF
11 specific developmental disorder 33.4 SLC6A4 SERPINA3 PRODH MIR9-1 MIR24-1 KDM4C
12 panic disorder 33.4 SLC6A4 MIR22 DRD2 BDNF
13 eating disorder 33.4 SLC6A4 DRD2 BDNF
14 substance abuse 33.2 SLC6A4 SERPINA3 PRODH H2AC18 DRD2 CCR6
15 fibromyalgia 33.1 SLC6A4 DRD2 BDNF
16 somatoform disorder 32.9 SLC6A4 H2AC18 BDNF
17 dementia, lewy body 32.9 SERPINA3 MIR132 BDNF APP APOE
18 personality disorder 32.9 SLC6A4 DRD2 BDNF
19 acute stress disorder 32.9 SLC6A4 SERPINA3 BDNF
20 mental depression 32.9 SLC6A4 SERPINA3 PRODH MIR9-1 MIR24-1 H2AC18
21 mood disorder 32.8 SLC6A4 PRODH MIR132 H2AC18 DRD2 BDNF
22 sleep disorder 32.8 SLC6A4 DRD2 BDNF
23 psychotic disorder 32.7 SLC6A4 SERPINA3 PRODH MIR9-1 MIR24-1 MIR132
24 alcohol use disorder 32.7 SLC6A4 PRODH KDM4C H2AC18 DRD2 CCR6
25 physical disorder 32.5 PRODH MIR9-1 MIR24-1 KDM4C H2AC18 ERCC6
26 wilson disease 32.4 DRD2 APP APOE
27 autism spectrum disorder 32.3 SLC6A4 PRODH MIR21 MIR132 DRD2 BDNF
28 autism 32.3 SLC6A4 PRODH KDM4C DRD2 BDNF APP
29 generalized anxiety disorder 32.3 SLC6A4 DRD2 BDNF
30 traumatic brain injury 32.3 DRD2 BDNF APOE
31 social phobia 32.2 SLC6A4 SERPINA3 PRODH DRD2
32 brain injury 32.2 DRD2 BDNF APOE
33 borderline personality disorder 32.1 SLC6A4 DRD2 BDNF
34 tobacco addiction 32.0 SLC6A4 H2AC18 DRD2 BDNF
35 substance dependence 32.0 SLC6A4 H2AC18 DRD2 BDNF
36 body mass index quantitative trait locus 11 32.0 SERPINA3 PRODH MIR9-1 MIR22 MIR21 KDM4C
37 phobia, specific 31.8 SLC6A4 SERPINA3 PRODH
38 drug dependence 31.8 SLC6A4 DRD2 BDNF
39 endogenous depression 31.6 SLC6A4 H2AC18 BDNF
40 pulmonary disease, chronic obstructive 31.6 SLC6A4 SERPINA3 H2AC18 EPRS1 CCR6
41 fetal alcohol syndrome 31.5 MIR9-1 KDM4C H2AC18 BDNF
42 phobic disorder 31.5 SLC6A4 SERPINA3 PRODH BDNF
43 alzheimer disease 31.5 SLC6A4 SERPINA3 MIR22 MIR132 DRD2 BDNF
44 irritable bowel syndrome 31.5 SLC6A4 MIR24-1 BDNF
45 bulimia nervosa 31.5 SLC6A4 DRD2 BDNF
46 amyotrophic lateral sclerosis 1 31.5 SERPINA3 PRODH MIR9-1 MIR24-1 MIR22 MIR132
47 dermatitis, atopic 31.4 SERPINA3 MIR21 H2AC18 CCR6 BDNF
48 skin disease 31.4 SERPINA3 PRODH MIR21 H2AC18 ERCC6 CCR6
49 cerebrovascular disease 31.4 SERPINA3 MIR21 MIR132 APP APOE
50 migraine with or without aura 1 31.4 SLC6A4 H2AC18 DRD2 BDNF

Graphical network of the top 20 diseases related to Disease of Mental Health:



Diseases related to Disease of Mental Health
Sources

Symptoms & Phenotypes for Disease of Mental Health

About this section

UMLS symptoms related to Disease of Mental Health:


agitation, lethargy, forgetful, decrease in appetite, symptoms, nervousness, feeling jittery, alexithymia, increased libido, numbness, psychiatric symptom, hallucinations, auditory, hallucinations, visual, numbness localized, feeling detached, feeling strange, feeling weightless, floating feeling, dejection emotional, depressed reaction, hallucinations, sensory, restless sleep, difficulty sleeping, excitability, depression aggravated, agitation mental, numb mouth, opiate withdrawal symptoms, clouded consciousness, trembling inside, sluggishness

MGI Mouse Phenotypes related to Disease of Mental Health:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 integument MP:0010771 9.28 APOE APP BDNF DRD2 EPRS1 ERCC6
Sources

Drugs & Therapeutics for Disease of Mental Health

About this section

Drugs for Disease of Mental Health (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 726)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Morphine Approved, Investigational Phase 4 57-27-2 5288826
2
Coal tar Approved Phase 4 8007-45-2
3
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
4
Racepinephrine Approved Phase 4 329-65-7 838
5
Ferrous succinate Approved Phase 4 10030-90-7
6
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
7
Ropivacaine Approved Phase 4 84057-95-4 71273 175805
8
Parathyroid hormone Approved, Investigational Phase 4 9002-64-6
9
Methimazole Approved Phase 4 60-56-0 1349907
10
Oxcarbazepine Approved Phase 4 28721-07-5 34312
11
Nifedipine Approved Phase 4 21829-25-4 4485
12
Amlodipine Approved Phase 4 88150-42-9 2162
13
Atenolol Approved Phase 4 29122-68-7 2249
14
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
15
Tocopherol Approved, Investigational Phase 4 1406-66-2, 54-28-4 14986
16
Amitriptyline Approved Phase 4 50-48-6 2160
17
Clozapine Approved Phase 4 5786-21-0 2818
18
Carbon monoxide Approved, Investigational Phase 4 630-08-0 281
19
Lamotrigine Approved, Investigational Phase 4 84057-84-1 3878
20
Amphetamine Approved, Illicit, Investigational Phase 4 300-62-9 5826 3007
21
Dextroamphetamine Approved, Illicit Phase 4 51-64-9 5826
22
Asenapine Approved Phase 4 85650-56-2, 65576-45-6 3001386
23
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
24
Valproic acid Approved, Investigational Phase 4 99-66-1 3121
25
Cyproheptadine Approved Phase 4 129-03-3 2913
26
Amisulpride Approved, Investigational Phase 4 71675-85-9, 53583-79-2 2159
27
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
28
Clonazepam Approved, Illicit Phase 4 1622-61-3 2802
29
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
30 Coconut Approved Phase 4
31
Iloperidone Approved Phase 4 133454-47-4 71360
32
Diazepam Approved, Illicit, Investigational, Vet_approved Phase 4 439-14-5 3016
33
Selegiline Approved, Investigational, Vet_approved Phase 4 14611-51-9 26757 5195
34
Perphenazine Approved Phase 4 58-39-9 4748
35
Cinnarizine Approved, Investigational Phase 4 298-57-7 2761 1547484
36
Curcumin Approved, Experimental, Investigational Phase 4 458-37-7 969516
37
Pimozide Approved Phase 4 2062-78-4 16362
38
Eszopiclone Approved, Investigational Phase 4 138729-47-2 969472
39
Tiagabine Approved, Investigational Phase 4 115103-54-3 60648
40
Zinc sulfate Approved, Investigational Phase 4 7733-02-0
41
Glucosamine Approved, Investigational Phase 4 3416-24-8 439213
42
Zolpidem Approved Phase 4 82626-48-0 5732
43
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
44
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
45
Pramlintide Approved, Investigational Phase 4 151126-32-8
46
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
47
Allantoin Approved Phase 4 97-59-6 204
48
Heparin Approved, Investigational Phase 4 9005-49-6 772 46507594
49
Hydromorphone Approved, Illicit Phase 4 466-99-9 5284570
50
Tamsulosin Approved, Investigational Phase 4 106133-20-4 129211

Interventional clinical trials:

(show top 50) (show all 5664)
# Name Status NCT ID Phase Drugs
1 Myoinositol for the Treatment of Ovarian and Psychiatric Disorder in PCOS Patients. Unknown status NCT01246310 Phase 4
2 Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic REM Sleep Behavior Disorder: a Pilot Study Unknown status NCT02836743 Phase 4 Circadin;Placebo
3 Randomized, Controlled Study of Iron Supplementation of Infants With Birth Weights 2000-2500 g Unknown status NCT00558454 Phase 4 Iron
4 Clinical Psychopharmacology Division Institute of Mental Health, Peking University Unknown status NCT03148535 Phase 4 Lithium Carbonate;lithium carbonate combined with SSRI antidepressant treatment
5 A Pilot Study to Determine if Pantoprazole Modifies Steady-State Plasma Concentrations of Orally Administered Psychotropic Medications Unknown status NCT02213887 Phase 4 Pantoprazole;Pantoprazole
6 Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis- An Investigator-initiated, Phase IV, Randomised Double-blind Multi-centre Trial of the Benefits and Harms of Aripiprazole Versus Quetiapine in Children and Adolescents With Psychosis Unknown status NCT01119014 Phase 4 Aripiprazole;Quetiapine
7 Aggressive Behaviour in Children With Tourette's Syndrome (TS) and Comorbid Attention Deficit Hyperactivity Disorder (ADHD) Unknown status NCT00152750 Phase 4 APO-clonidine
8 A Pilot Study to Determine How Frequency of Administration Modifies Steady-State Plasma Concentrations of Orally Administered Clozapine Unknown status NCT02286206 Phase 4 Clozapine
9 Reduction of Cardiovascular Risk in Severe Mental Illness Prescribing and Using Better and More Appropriated Drugs Unknown status NCT01182012 Phase 4
10 A Randomized Controlled Trial of Antidepressant Maintenance for Major Depression Following Mild Traumatic Brain Injury Unknown status NCT00162916 Phase 4 citalopram;Placebo
11 Effects of N-Acetyl-Cysteine on Oxidative Stress Biomarkers in Bipolar Patients With and Without Tobacco Use Disorder Unknown status NCT02252341 Phase 4
12 The Effect of a Community-based Long-acting Antipsychotic-treated Management Model on the Violence Risk of Patients With Schizophrenia: a 1-year, Open-label Randomized Controlled Study Unknown status NCT03080194 Phase 4 paliperidone palmitate;control group
13 Cardiopulmonary Capacity In Different Quartiles Ranges Of Reference For Serum Thyroid Stimulating Hormone (TSH): Sectional Evaluation And Effect Of The Use Of Methimazole In Elderly Population Unknown status NCT01849861 Phase 4 Methimazole
14 Evaluation of the Efficacy of Repetitive Transcranial Magnetic Stimulation on Cognitive, Anxiety and Depressive Symptoms in Patients Diagnosed With Major Depressive Disorder Unknown status NCT02213016 Phase 4
15 Phase 4 Study of Vitamin D3 Supplementation for Outcomes in Patients With Unipolar Depression Unknown status NCT01390662 Phase 4
16 Group Mindfulness-Based Cognitive Therapy for the Treatment of Late-Life Depression and Anxiety Symptoms in Primary Care: A Randomized Controlled Trial Unknown status NCT02777905 Phase 4
17 Study on the Effect of Combined Oral Contraceptive Therapy on Female Sexuality, Body Image and Mental Health Unknown status NCT02613039 Phase 4 Combined Estrogen-Progestin Oral Contraceptives
18 Hyperventilation and ECT Seizure Duration: Effects on Cerebral Oxygen Saturation, and Therapeutic Outcome With Comparisons Between Etomidate and Ketamine in Patients With Major Depressive Disorder Unknown status NCT02924090 Phase 4 Etomidate;Ketamine
19 Efficacy of Exposure and Response Prevention（ERP） and SSRIs, and Its Predictors in Obsessive-Compulsive Disorder Unknown status NCT02022709 Phase 4 Fluoxetine;Sertraline;Paroxetine;Citalopram;Fluvoxamine
20 The Assessment of Efficacy and Tolerability of Methylphenidate vs. Risperidone in the Treatment of Children and Adolescents With ADHD and Disruptive Disorders Unknown status NCT02063945 Phase 4 Methylphenidate;Risperidone
21 Determining the Efficacy and Tolerance of Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute Psychiatry Unknown status NCT00986167 Phase 4 Quetiapine XR
22 Comparative Efficacy and Acceptability of Lithium, Valproate, Oxcarbazepine, Quetiapine, Olanzapine, and Ziprasidone in Bipolar I Disorder, Manic or Mixed Phase Unknown status NCT01893229 Phase 4 Lithium;Valproate;Oxcarbazepine;Quetiapine;Olanzapine;Ziprasidone
23 The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope Unknown status NCT01357967 Phase 4 SSRI monotherapy;Seroquel XR adjunctive
24 Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone Unknown status NCT00480844 Phase 4 Sertindole;Risperidone
25 Metformin for Weight Control in Adolescents Taking Atypical Antipsychotics- Double Blind Placebo Controlled Study Unknown status NCT00845936 Phase 4 Metformin
26 Prospective, Interventional Multicentre Study on the Effect of Deepening of Sedation on Intra-abdominal Pressure Unknown status NCT02944292 Phase 4 Propofol
27 A Randomized Controlled Study of Nifecardia SRFC (Nifedipine) and Adalat OROS (Nifedipine) in the Treatment of Patients With Essential Hypertension Unknown status NCT00173667 Phase 4 Nifedipine 30 mg GITS
28 The Monitor of Serum Prolactin Level and Related Clinical Observations Among Individuals With Schizophrenia Spectrum Illnesses in a 3 Months Aripiprazole Trial Unknown status NCT00468533 Phase 4 Aripiprazole
29 Treatment With Escitalopram (Cipralex®) for Adolescents With Obsessive-Compulsive Disorder: Efficacy, Safety, and Changes in Executive Functions, Metacognition, and Regional Brain Activations. Unknown status NCT00708240 Phase 4 Escitalopram
30 Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With Treatment: An Open and Randomized Clinical Trial Unknown status NCT00813722 Phase 4 amlodipine (calcium chanel blocker) and losartan (at1 antagonist);atenolol (beta blocker) and hydrochlorothiazide (diuretic)
31 A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Aptensio XR® in Children Ages 4 to Under 6 Years Diagnosed With Attention Deficit-Hyperactivity Disorder (ADHD) Unknown status NCT02683265 Phase 4 Aptensio XR;Placebo
32 Frailty and Cognitive Function Assessment of TAVI Patients (The Hungarian Frailty Score) - Observational, Prospective, Singe Center Study Unknown status NCT02650388 Phase 4
33 Development of a Nationally Scalable Model of Group Prenatal Care to Improve Birth Outcomes: "Expect With Me" Unknown status NCT02169024 Phase 4
34 Postoperative Pain Relief Following Total Hip Arthroplasty. A Comparison Between Intrathecal Morphine (IM) and Local Infiltration Analgesia (LIA) Unknown status NCT01281891 Phase 4 LIA;I/T morphine
35 MRI With a Lymph Node Specific Contrast Agent: an Alternative for CT-Scanning and Lymph Node Dissection in Patients With Prostate Cancer? Unknown status NCT00185029 Phase 4
36 Joining Forces: Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana Completed NCT02593734 Phase 4 olanzapine;risperidone;amitryptaline;fluoxetine
37 Randomized Controlled Trial of a Community-based Early Psychiatric Intervention Strategy to Screen and Manage Depression in the Elderly Completed NCT00430404 Phase 4
38 A Randomised Controlled Trial on the Effectiveness of Screening and Brief Counselling for Elderly Patients With Psychological Problems in Primary Care. Completed NCT00283270 Phase 4
39 Phase IV Study of Effectiveness of Aripiprazole, Quetiapine, and Ziprasidone in the Treatment of First Episode of Non-affective Psychosis Individuals Included in the First Episode Psychosis Clinical Program II (PAFIP II): a 3-year Follow-up Completed NCT02526030 Phase 4 Aripiprazole;Quetiapine;Ziprasidone
40 Phase IV Study of the Effectiveness of Aripiprazole, Quetiapine, and Ziprasidone in the Treatment of First Episode of Non-affective Psychosis Individuals Included in the First Episode Psychosis Clinical Program II (PAFIP II) Completed NCT02305823 Phase 4 Aripiprazole;Quetiapine;Ziprasidone
41 Efficacy and Safety of Aripiprazole in Patients With First Episode Psychosis: an Open-label, Prospective Multi-center Study Completed NCT01026584 Phase 4 Aripiprazole
42 Efficacy and Safety of Paliperidone ER in Patients With First Episode Psychosis: an Open-label, Prospective Multi-center Study Completed NCT01157585 Phase 4 paliperidone ER
43 Efficacy and Safety With Ziprasidone in the Treatment of First-episode Schizophrenia Spectrum Disorder: Multi-center Study Completed NCT01157559 Phase 4 Ziprasidone
44 Feasibility Trial of a Tailored Smoking Cessation App for People With Serious Mental Illness Completed NCT03069482 Phase 4 Nicotine patch;Nicotine lozenge
45 Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: a Randomized Comparison of Aripiprazole, Quetiapine and Ziprasidone Over 1 Year Completed NCT02534363 Phase 4 Aripiprazole;Quetiapine;Ziprasidone
46 Evaluation of Growth, Sexual Maturation, and Prolactin-Related Adverse Events in the Pediatric Population Exposed to Atypical Antipsychotic Drugs Completed NCT01050582 Phase 4 Risperidone;Other atypical antipsychotic drugs
47 Combined Mirtazapine and Selective Serotonin Reuptake Inhibitor (SSRI) Treatment of Post-traumatic Stress Disorder (PTSD) Completed NCT01178671 Phase 4 Mirtazapine;Sertraline
48 Post-marketing Clinical Study on PAXIL Tablet in Patients With Depression or Depressive Mood - A Study on Combination of PAXIL Tablet and Benzodiazepines Completed NCT00259883 Phase 4 paroxetine
49 A Multi-Center Study to Examine The Clinical Effects of Cross Titration of Antipsychotics With Ziprasidone in Subjects With Schizophrenia or Schizoaffective Disorder Completed NCT00137020 Phase 4 ziprasidone
50 The Cognitive Effects of Risperidone and Olanzapine Completed NCT00108368 Phase 4 Risperidone;Olanzapine

Search NIH Clinical Center for Disease of Mental Health

Cochrane evidence based reviews: mental disorders

Sources

Genetic Tests for Disease of Mental Health

About this section
Sources

Anatomical Context for Disease of Mental Health

About this section

MalaCards organs/tissues related to Disease of Mental Health:

40
Brain, Testes, Heart, Breast, Eye, Prostate, Lung
Sources

Publications for Disease of Mental Health

About this section

Articles related to Disease of Mental Health:

(show top 50) (show all 30002)
# Title Authors PMID Year
1
Mental health and offending in older people: Future directions for research. 61 42
31418962 2019
2
Structured multi-disciplinary psychosocial care for cancer patients and the perceived quality of care from the patient perspective: a cluster-randomized trial. 42
31506739 2019
3
Project ESTEEM protocol: a randomized controlled trial of an LGBTQ-affirmative treatment for young adult sexual minority men's mental and sexual health. 42
31399071 2019
4
Mental health care in Pakistan boosted by the highest office. 61
31868627 2020
5
Mental health in conflict settings. 61
31868621 2020
6
Mental health in conflict settings. 61
31868622 2020
7
Mental health in conflict settings - Authors' reply. 61
31868624 2020
8
Asian American mental health: Longitudinal trend and explanatory factors among young Filipino- and Korean Americans. 61
32021900 2020
9
Correlations between healthcare provider interactions and mental health among transgender and nonbinary adults. 61
31872041 2020
10
Child living arrangements following separation and mental health of parents in Sweden. 61
31799363 2020
11
Best Practice Principles When Working With Individuals With Intellectual Disability and Comorbid Mental Health Concerns. 61
31328633 2020
12
Socioeconomic Status and Later-life Mental Health in South Korea. 61
32019653 2020
13
Harnessing Wise Interventions to Advance the Potency and Reach of Youth Mental Health Services. 61
31440858 2020
14
Childhood Trauma, Social Networks, and the Mental Health of Adult Survivors. 61
29294679 2020
15
Perceived Feasibility, Acceptability, and Cultural Adaptation for a Mental Health Intervention in Rural Haiti. 61
31228034 2020
16
Provider Perspectives on Stressors, Support, and Access to Mental Health Care for Latinx Youth. 61
31339447 2020
17
Asylum-seekers' psychosocial situation: A diathesis for post-migratory stress and mental health disorders? 61
31935528 2020
18
Bullying Environment Moderates the Relationship Between Exercise and Mental Health in Bullied US Children. 61
31859403 2020
19
A Complexity Perspective on Narrative Identity Reconstruction in Mental Health Recovery. 61
31729934 2020
20
Family-Based Mental Health Promotion for Somali Bantu and Bhutanese Refugees: Feasibility and Acceptability Trial. 61
31699604 2020
21
Sounding the Alarm About Mental Health and Substance Use Disorders in Hispanic/Latino Communities. 61
31878799 2020
22
The epidemiology of alcohol use disorders cross-nationally: Findings from the World Mental Health Surveys. 61
31865172 2020
23
Moral Experiences of Crisis Management in a Child Mental Health Setting: A Participatory Hermeneutic Ethnographic Study. 61
31218498 2020
24
Communicative Predictors of Older Adults' Successful Aging, Mental Health, and Alcohol Use. 61
29983078 2020
25
Childhood adversity and mental health comorbidity in men and women with opioid use disorders. 61
31855783 2020
26
Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. 61
32032543 2020
27
The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. 61
32035030 2020
28
Job Burnout Among Mental Health Staff at a Veterans Affairs Psychosocial Rehabilitation Center. 61
31587114 2020
29
An Integrative Review of School-Based Mental Health Interventions and Implications for Psychogenic Nonepileptic Seizures. 61
31179824 2020
30
Feasibility of implementing mobile technology-delivered mental health treatment in routine adult sickle cell disease care. 61
30508141 2020
31
Resilience of African migrant women: Implications for mental health practice. 61
31917517 2020
32
Training and advocacy for mental health in the Pacific Islands. 61
32013549 2020
33
Child mental health services in England: a continuing crisis. 61
32035530 2020
34
Positive Mental Health, Stressful Life Events, and Suicide Ideation. 61
32036702 2020
35
Mental health first aid for the UK Armed Forces. 61
30715280 2020
36
Indigenous mental health: the limits of medicalised solutions. 61
31530162 2020
37
Assessment of mental health among nursing staff at different levels. 61
32028420 2020
38
Factors associated with benzodiazepine prescribing in community mental health settings. 61
31856952 2020
39
Engagement of ethnic minorities in mental health care. 61
31922667 2020
40
Inflammation affects social experience: implications for mental health. 61
31922673 2020
41
Encounter mental health in Tuvalu: The prior study. 61
31496274 2020
42
Science needs better reporting to improve translational mental health research. 61
31533442 2020
43
Telepsychiatry Use in U.S. Mental Health Facilities, 2010-2017. 61
31615370 2020
44
The remarkable (Disappearing Act of the) mental health nurse psychotherapist. 61
32011061 2020
45
What is good mental health? A scoping review. 61
31901337 2020
46
Social interventions: a new era for global mental health? 61
31653556 2020
47
Unburden mental health in India: it's time to act now. 61
31879246 2020
48
Mental health and detention: an unhappy co-occurrence. 61
31956015 2020
49
The BASIC group: closing mental health-care gaps for children. 61
31981537 2020
50
The Mental Health Hazards of Reading About Physician Suicide. 61
32040159 2020
Sources

Variations for Disease of Mental Health

About this section

ClinVar genetic disease variations for Disease of Mental Health:

6 ‎‎ ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 LOC730100 NC_000002.10:g.51151955_51190352del38398deletion no interpretation for the single variant 242471 2:51298451-51336848 2:51071313-51109710
2 LOC730100 NC_000002.10:g.51440969_51481281del40313deletion no interpretation for the single variant 242470 2:51587465-51627777 2:51360327-51400639
Sources

Expression for Disease of Mental Health

About this section
Search GEO for disease gene expression data for Disease of Mental Health.
Sources

Pathways for Disease of Mental Health

About this section
Sources

GO Terms for Disease of Mental Health

About this section

Cellular components related to Disease of Mental Health according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.28 SERPINA3 MIR24-1 MIR22 MIR21 MIR132 BLOC1S1

Biological processes related to Disease of Mental Health according to GeneCards Suite gene sharing:

(show all 11)
# Name GO ID Score Top Affiliating Genes
1 negative regulation of gene expression GO:0010629 9.76 MIR21 MIR132 APP APOE
2 response to toxic substance GO:0009636 9.67 SLC6A4 ERCC6 DRD2
3 miRNA mediated inhibition of translation GO:0035278 9.65 MIR9-1 MIR21 MIR132
4 neuron projection development GO:0031175 9.56 ERCC6 BLOC1S1 APP APOE
5 gene silencing by miRNA GO:0035195 9.55 MIR9-1 MIR24-1 MIR22 MIR21 MIR132
6 negative regulation of blood vessel endothelial cell migration GO:0043537 9.54 MIR24-1 MIR132 APOE
7 negative regulation of endothelial cell proliferation GO:0001937 9.5 MIR22 MIR21 APOE
8 negative regulation of long-term synaptic potentiation GO:1900272 9.43 APP APOE
9 positive regulation of gene expression GO:0010628 9.43 SLC6A4 MIR21 MIR132 KDM4C ERCC6 APP
10 positive regulation of amyloid fibril formation GO:1905908 9.4 APP APOE
11 positive regulation of ERK1 and ERK2 cascade GO:0070374 9.02 MIR24-1 MIR21 DRD2 APP APOE

Molecular functions related to Disease of Mental Health according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 mRNA binding involved in posttranscriptional gene silencing GO:1903231 9.02 MIR9-1 MIR24-1 MIR22 MIR21 MIR132
Sources

Sources for Disease of Mental Health

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....